JP2013056854A - 口腔用組成物 - Google Patents
口腔用組成物 Download PDFInfo
- Publication number
- JP2013056854A JP2013056854A JP2011196314A JP2011196314A JP2013056854A JP 2013056854 A JP2013056854 A JP 2013056854A JP 2011196314 A JP2011196314 A JP 2011196314A JP 2011196314 A JP2011196314 A JP 2011196314A JP 2013056854 A JP2013056854 A JP 2013056854A
- Authority
- JP
- Japan
- Prior art keywords
- acid
- cinnamic acid
- biofilm formation
- biofilm
- caries
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 23
- 230000032770 biofilm formation Effects 0.000 claims abstract description 47
- WBYWAXJHAXSJNI-UHFFFAOYSA-N methyl p-hydroxycinnamate Natural products OC(=O)C=CC1=CC=CC=C1 WBYWAXJHAXSJNI-UHFFFAOYSA-N 0.000 claims abstract description 47
- 235000013985 cinnamic acid Nutrition 0.000 claims abstract description 42
- WBYWAXJHAXSJNI-VOTSOKGWSA-M .beta-Phenylacrylic acid Natural products [O-]C(=O)\C=C\C1=CC=CC=C1 WBYWAXJHAXSJNI-VOTSOKGWSA-M 0.000 claims abstract description 41
- 229930016911 cinnamic acid Natural products 0.000 claims abstract description 41
- WBYWAXJHAXSJNI-SREVYHEPSA-N Cinnamic acid Chemical compound OC(=O)\C=C/C1=CC=CC=C1 WBYWAXJHAXSJNI-SREVYHEPSA-N 0.000 claims abstract description 38
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 claims abstract description 20
- 239000003112 inhibitor Substances 0.000 claims description 9
- 229940123361 Quorum sensing inhibitor Drugs 0.000 claims description 5
- 210000000214 mouth Anatomy 0.000 claims description 5
- 239000002324 mouth wash Substances 0.000 claims description 4
- 229940051866 mouthwash Drugs 0.000 claims description 4
- 229940034610 toothpaste Drugs 0.000 claims description 4
- 239000000606 toothpaste Substances 0.000 claims description 4
- 235000013305 food Nutrition 0.000 claims description 3
- 239000007937 lozenge Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 23
- 230000001629 suppression Effects 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 description 31
- 208000002925 dental caries Diseases 0.000 description 30
- 241000894006 Bacteria Species 0.000 description 28
- 241000194019 Streptococcus mutans Species 0.000 description 11
- ZYOPDNLIHHFGEC-FNORWQNLSA-N Trans-2, 3, 4-Trimethoxycinnamate Chemical compound COC1=CC=C(\C=C\C(O)=O)C(OC)=C1OC ZYOPDNLIHHFGEC-FNORWQNLSA-N 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000003242 anti bacterial agent Substances 0.000 description 9
- 150000001875 compounds Chemical group 0.000 description 9
- 244000005700 microbiome Species 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 238000009472 formulation Methods 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- 238000000034 method Methods 0.000 description 8
- 230000018612 quorum sensing Effects 0.000 description 8
- 235000009508 confectionery Nutrition 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 125000001424 substituent group Chemical group 0.000 description 5
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 4
- DEUFHLFQPMURDV-UHFFFAOYSA-N Dimethoxycinnamic acid Chemical group COC(C(O)=O)=C(OC)C1=CC=CC=C1 DEUFHLFQPMURDV-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- 230000001419 dependent effect Effects 0.000 description 4
- 230000014509 gene expression Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 4
- KJPRLNWUNMBNBZ-QPJJXVBHSA-N (E)-cinnamaldehyde Chemical compound O=C\C=C\C1=CC=CC=C1 KJPRLNWUNMBNBZ-QPJJXVBHSA-N 0.000 description 3
- AXMVYSVVTMKQSL-UHFFFAOYSA-N UNPD142122 Natural products OC1=CC=C(C=CC=O)C=C1O AXMVYSVVTMKQSL-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 3
- 235000015218 chewing gum Nutrition 0.000 description 3
- 229940112822 chewing gum Drugs 0.000 description 3
- CCRCUPLGCSFEDV-UHFFFAOYSA-N cinnamic acid methyl ester Natural products COC(=O)C=CC1=CC=CC=C1 CCRCUPLGCSFEDV-UHFFFAOYSA-N 0.000 description 3
- KJPRLNWUNMBNBZ-UHFFFAOYSA-N cinnamic aldehyde Natural products O=CC=CC1=CC=CC=C1 KJPRLNWUNMBNBZ-UHFFFAOYSA-N 0.000 description 3
- 229940117916 cinnamic aldehyde Drugs 0.000 description 3
- 230000001332 colony forming effect Effects 0.000 description 3
- 230000003247 decreasing effect Effects 0.000 description 3
- CCRCUPLGCSFEDV-BQYQJAHWSA-N methyl trans-cinnamate Chemical compound COC(=O)\C=C\C1=CC=CC=C1 CCRCUPLGCSFEDV-BQYQJAHWSA-N 0.000 description 3
- 239000001301 oxygen Substances 0.000 description 3
- 229910052760 oxygen Inorganic materials 0.000 description 3
- 208000028169 periodontal disease Diseases 0.000 description 3
- 230000003449 preventive effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- OARRHUQTFTUEOS-UHFFFAOYSA-N safranin Chemical compound [Cl-].C=12C=C(N)C(C)=CC2=NC2=CC(C)=C(N)C=C2[N+]=1C1=CC=CC=C1 OARRHUQTFTUEOS-UHFFFAOYSA-N 0.000 description 3
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 2
- JPQWWJZORKTMIZ-ZZXKWVIFSA-N 2,5-Dimethoxycinnamic acid Chemical compound COC1=CC=C(OC)C(\C=C\C(O)=O)=C1 JPQWWJZORKTMIZ-ZZXKWVIFSA-N 0.000 description 2
- HJBWJAPEBGSQPR-GQCTYLIASA-N 3,4-dimethoxycinnamic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1OC HJBWJAPEBGSQPR-GQCTYLIASA-N 0.000 description 2
- QAXPUWGAGVERSJ-UHFFFAOYSA-N 3-(2,3-dimethoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=CC(C=CC(O)=O)=C1OC QAXPUWGAGVERSJ-UHFFFAOYSA-N 0.000 description 2
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical compound OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 2
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 206010006326 Breath odour Diseases 0.000 description 2
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 208000035473 Communicable disease Diseases 0.000 description 2
- HJBWJAPEBGSQPR-UHFFFAOYSA-N DMCA Natural products COC1=CC=C(C=CC(O)=O)C=C1OC HJBWJAPEBGSQPR-UHFFFAOYSA-N 0.000 description 2
- 208000002064 Dental Plaque Diseases 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 235000004883 caffeic acid Nutrition 0.000 description 2
- 229940074360 caffeic acid Drugs 0.000 description 2
- 150000001732 carboxylic acid derivatives Chemical class 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- -1 cinnamic acid analog structure compound Chemical class 0.000 description 2
- 150000001851 cinnamic acid derivatives Chemical class 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 2
- 235000001785 ferulic acid Nutrition 0.000 description 2
- 229940114124 ferulic acid Drugs 0.000 description 2
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 235000015110 jellies Nutrition 0.000 description 2
- 239000008274 jelly Substances 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 230000007505 plaque formation Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- RODXRVNMMDRFIK-UHFFFAOYSA-N scopoletin Chemical group C1=CC(=O)OC2=C1C=C(OC)C(O)=C2 RODXRVNMMDRFIK-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- RUVINXPYWBROJD-ONEGZZNKSA-N trans-anethole Chemical group COC1=CC=C(\C=C\C)C=C1 RUVINXPYWBROJD-ONEGZZNKSA-N 0.000 description 2
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 2
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 2
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 2
- 235000012141 vanillin Nutrition 0.000 description 2
- 229940117960 vanillin Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 1
- AFDXODALSZRGIH-QPJJXVBHSA-N (E)-3-(4-methoxyphenyl)prop-2-enoic acid Chemical compound COC1=CC=C(\C=C\C(O)=O)C=C1 AFDXODALSZRGIH-QPJJXVBHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- YEMUSDCFQUBPAL-SNAWJCMRSA-N (e)-3-(3-bromophenyl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=CC(Br)=C1 YEMUSDCFQUBPAL-SNAWJCMRSA-N 0.000 description 1
- RTSIUKMGSDOSTI-SNAWJCMRSA-N (e)-3-(3-fluorophenyl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=CC(F)=C1 RTSIUKMGSDOSTI-SNAWJCMRSA-N 0.000 description 1
- CPDDDTNAMBSPRN-ZZXKWVIFSA-N (e)-3-(4-bromophenyl)prop-2-enoic acid Chemical compound OC(=O)\C=C\C1=CC=C(Br)C=C1 CPDDDTNAMBSPRN-ZZXKWVIFSA-N 0.000 description 1
- WAHYZVVZFNUXSC-TWGDSDBMSA-N (e)-3-[4-[(2e)-3,7-dimethylocta-2,6-dienoxy]-3-methoxyphenyl]prop-2-enoic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1OC\C=C(/C)CCC=C(C)C WAHYZVVZFNUXSC-TWGDSDBMSA-N 0.000 description 1
- VEEPGIBHWRABJA-UHFFFAOYSA-N 1-benzyl-3,5-dimethylpyrazol-4-amine Chemical compound CC1=C(N)C(C)=NN1CC1=CC=CC=C1 VEEPGIBHWRABJA-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- XYHKNCXZYYTLRG-UHFFFAOYSA-N 1h-imidazole-2-carbaldehyde Chemical compound O=CC1=NC=CN1 XYHKNCXZYYTLRG-UHFFFAOYSA-N 0.000 description 1
- ZYDQSPYFLQSONW-UHFFFAOYSA-N 2,3-dimethoxy-3-(2-methoxyphenyl)prop-2-enoic acid Chemical compound COC(C(O)=O)=C(OC)C1=CC=CC=C1OC ZYDQSPYFLQSONW-UHFFFAOYSA-N 0.000 description 1
- FODBVCSYJKNBLO-UHFFFAOYSA-N 2,3-dimethoxybenzoic acid Chemical group COC1=CC=CC(C(O)=O)=C1OC FODBVCSYJKNBLO-UHFFFAOYSA-N 0.000 description 1
- PKZJLOCLABXVMC-UHFFFAOYSA-N 2-Methoxybenzaldehyde Chemical group COC1=CC=CC=C1C=O PKZJLOCLABXVMC-UHFFFAOYSA-N 0.000 description 1
- FEGVSPGUHMGGBO-UHFFFAOYSA-N 2-methoxy cinnamic acid Natural products COC1=CC=CC=C1C=CC(O)=O FEGVSPGUHMGGBO-UHFFFAOYSA-N 0.000 description 1
- CNXZMGRWEYQCOQ-UHFFFAOYSA-N 2-methoxy-3-phenylprop-2-enoic acid Chemical compound COC(C(O)=O)=CC1=CC=CC=C1 CNXZMGRWEYQCOQ-UHFFFAOYSA-N 0.000 description 1
- WLAMNBDJUVNPJU-UHFFFAOYSA-N 2-methylbutyric acid Chemical compound CCC(C)C(O)=O WLAMNBDJUVNPJU-UHFFFAOYSA-N 0.000 description 1
- YTFVRYKNXDADBI-SNAWJCMRSA-N 3,4,5-trimethoxycinnamic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC(OC)=C1OC YTFVRYKNXDADBI-SNAWJCMRSA-N 0.000 description 1
- WAHYZVVZFNUXSC-VKSNPQIYSA-N 3-(4'-Geranyloxy-3'-methoxyphenyl)-2-trans propenoic acid Natural products O=C(O)/C=C/c1cc(OC)c(OC/C=C(\CC/C=C(\C)/C)/C)cc1 WAHYZVVZFNUXSC-VKSNPQIYSA-N 0.000 description 1
- VFQOFJQVKVEXIY-UHFFFAOYSA-N 3-(phenylmethoxycarbonylamino)-3-piperidin-3-ylpropanoic acid Chemical compound C1CCNCC1C(CC(=O)O)NC(=O)OCC1=CC=CC=C1 VFQOFJQVKVEXIY-UHFFFAOYSA-N 0.000 description 1
- LZPNXAULYJPXEH-AATRIKPKSA-N 3-Methoxycinnamic acid Chemical compound COC1=CC=CC(\C=C\C(O)=O)=C1 LZPNXAULYJPXEH-AATRIKPKSA-N 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-M 3-Methylbutanoic acid Natural products CC(C)CC([O-])=O GWYFCOCPABKNJV-UHFFFAOYSA-M 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- KKEUGGZODLCCTR-UHFFFAOYSA-N 3-methyl-5-(trifluoromethyl)-4h-1,2-oxazol-5-ol Chemical compound CC1=NOC(O)(C(F)(F)F)C1 KKEUGGZODLCCTR-UHFFFAOYSA-N 0.000 description 1
- JZINNAKNHHQBOS-AATRIKPKSA-N 3-methylcinnamic acid Chemical compound CC1=CC=CC(\C=C\C(O)=O)=C1 JZINNAKNHHQBOS-AATRIKPKSA-N 0.000 description 1
- BYHBHNKBISXCEP-QPJJXVBHSA-N 4-acetoxycinnamic acid Chemical compound CC(=O)OC1=CC=C(\C=C\C(O)=O)C=C1 BYHBHNKBISXCEP-QPJJXVBHSA-N 0.000 description 1
- DZLOUWYGNATKKZ-UHFFFAOYSA-N 4-ethoxycinnamic acid Natural products CCOC1=CC=C(C=CC(O)=O)C=C1 DZLOUWYGNATKKZ-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 244000036385 Acronychia baueri Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- XEHFSYYAGCUKEN-UHFFFAOYSA-N Dihydroscopoletin Chemical group C1CC(=O)OC2=C1C=C(OC)C(O)=C2 XEHFSYYAGCUKEN-UHFFFAOYSA-N 0.000 description 1
- 229920002444 Exopolysaccharide Polymers 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229940127551 Glucosyl Transferase Inhibitors Drugs 0.000 description 1
- 229940122959 Glucosyltransferase inhibitor Drugs 0.000 description 1
- 229920002306 Glycocalyx Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 208000032139 Halitosis Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- YTFVRYKNXDADBI-UHFFFAOYSA-N O-Methylsinapic acid Natural products COC1=CC(C=CC(O)=O)=CC(OC)=C1OC YTFVRYKNXDADBI-UHFFFAOYSA-N 0.000 description 1
- 208000025157 Oral disease Diseases 0.000 description 1
- 208000005888 Periodontal Pocket Diseases 0.000 description 1
- 108010029987 Salivary Proteins and Peptides Proteins 0.000 description 1
- 102000001848 Salivary Proteins and Peptides Human genes 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241001521783 Streptococcus mutans UA159 Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940011037 anethole Drugs 0.000 description 1
- 229940124350 antibacterial drug Drugs 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- GWYFCOCPABKNJV-UHFFFAOYSA-N beta-methyl-butyric acid Natural products CC(C)CC(O)=O GWYFCOCPABKNJV-UHFFFAOYSA-N 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 230000001680 brushing effect Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 210000004517 glycocalyx Anatomy 0.000 description 1
- 230000009422 growth inhibiting effect Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 208000030194 mouth disease Diseases 0.000 description 1
- 235000015205 orange juice Nutrition 0.000 description 1
- BYHBHNKBISXCEP-UHFFFAOYSA-N p-acetoxy-cinnamic acid Natural products CC(=O)OC1=CC=C(C=CC(O)=O)C=C1 BYHBHNKBISXCEP-UHFFFAOYSA-N 0.000 description 1
- AFDXODALSZRGIH-UHFFFAOYSA-N p-coumaric acid methyl ether Natural products COC1=CC=C(C=CC(O)=O)C=C1 AFDXODALSZRGIH-UHFFFAOYSA-N 0.000 description 1
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Chemical group COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 1
- DYUMLJSJISTVPV-UHFFFAOYSA-N phenyl propanoate Chemical compound CCC(=O)OC1=CC=CC=C1 DYUMLJSJISTVPV-UHFFFAOYSA-N 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000000069 prophylactic effect Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- FWYIBGHGBOVPNL-UHFFFAOYSA-N scopoletin Chemical group COC=1C=C2C=CC(OC2=C(C1)O)=O FWYIBGHGBOVPNL-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- UAXOELSVPTZZQG-UHFFFAOYSA-N tiglic acid Natural products CC(C)=C(C)C(O)=O UAXOELSVPTZZQG-UHFFFAOYSA-N 0.000 description 1
- 241001148471 unidentified anaerobic bacterium Species 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G3/00—Sweetmeats; Confectionery; Marzipan; Coated or filled products
- A23G3/34—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof
- A23G3/36—Sweetmeats, confectionery or marzipan; Processes for the preparation thereof characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23G—COCOA; COCOA PRODUCTS, e.g. CHOCOLATE; SUBSTITUTES FOR COCOA OR COCOA PRODUCTS; CONFECTIONERY; CHEWING GUM; ICE-CREAM; PREPARATION THEREOF
- A23G4/00—Chewing gum
- A23G4/06—Chewing gum characterised by the composition containing organic or inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Inorganic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Polymers & Plastics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Birds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicinal Preparation (AREA)
Abstract
【解決手段】少なくとも1種のけい皮酸またはその類縁体を含有する口腔用組成物であって、けい皮酸またはその類縁体が少なくとも1つのメトキシ基を有することを特徴とする。
【選択図】なし
Description
すなわち、本発明は、虫歯菌が虫歯バイオフィルムを形成するクオラムセンシングシステムを抑制することにより虫歯を予防するものであり、そのクオラムセンシング抑制剤をけい皮酸とその類縁体に見出したものである。
さらに、本発明は、少なくとも1種のけい皮酸またはその類縁体を含有するクオラムセンシング抑制剤に関し、けい皮酸が、少なくとも1つのメトキシ基を有するクオラムセンシング抑制剤に関する。
1.けい皮酸、類縁体の各個別の活性(図1)
2.けい皮酸、けい皮アルデヒド、けい皮酸メチルの用量変化による活性(図2)
3.けい皮酸、フェニルプロピオン酸の活性比較(図3)
4.けい皮酸の 置換基の相違による活性比較(図4)
5.3種のメトキシ基の置換位置が相違するジメトキシけい皮酸の活性(図5)
6.けい皮酸に導入されたメトキシ基の数による活性の差(図6)
(けい皮酸およびその類縁体のバイオフィルム形成抑制活性評価)
(1−1)披験物質
けい皮酸および類縁体として、披験物質のけい皮酸、バニリン、フェルラ酸、クロロゲン酸、カフェ酸、p-クマル酸、けい皮アルデヒド、けい皮酸メチル、フェニルプロピオン酸、2-メトキシけい皮酸、3-メトキシけい皮酸、4-メトキシけい皮酸、3-ブロモけい皮酸、3-フルオロけい皮酸、3-メチルけい皮酸、4-アセトキシけい皮酸、4-ブロモけい皮酸、4-エトキシけい皮酸、4-フルオロけい皮酸、3,4-ジメトキシけい皮酸、2,3-ジメトキシけい皮酸、2,5-ジメトキシけい皮酸、2,3,4-トリメトキシけい皮酸、3,4,5-トリメトキシけい皮酸は全て市販特級品を用いた。
S. mutans UA159株を5mlのBrain Heart Infusion(BHI)液体培地にて37℃で10時間嫌気培養し、3000rpmで10分間遠心分離して集めた細菌を、PBSにてOD550nm=0.5に調製し、これを供試菌懸濁液とした。バイオフィルム形成は、96穴マイクロプレートを用いて試験を行った。各ウェルに、バイオフィルム形成阻害サンプル60μl、CSP20μl、S. mutans供試菌懸濁液20μl、0.1% Sucrose添加 Todd Hewitt Broth 100μlを添加し、37℃で5%CO2条件下で16時間培養を行った。
上記培養後の上清を取り除き、PBSにて2回各ウェルの洗浄を行った。洗浄後、各ウェルに0.25%サフラニン溶液を添加し15分間静置後余剰サフラニン溶液を取り除き、PBSにて2回各ウェルの洗浄を行った。洗浄後各ウェルにエタノールを添加し、30分間振盪することで染色させたサフラニンを溶出させ、マイクロプレートリーダーを用いて492nmの吸光度を測定し、バイオフィルム形成量を定量した。
バイオフィルム形成量は、サンプルを添加していないときの形成量を100としたときの割合で示した。
けい皮酸および類似化合物について:
けい皮酸およびけい皮酸類似構造化合物のバイオフィルム形成抑制効果を図1に示した。けい皮酸、p-クマル酸、カフェ酸を添加したときに、バイオフィルム形成量は約20%低下した。一方、クロロゲン酸、フェルラ酸、バニリンを添加したときにはバイオフィルム形成量は変わらず、類似構造化合物でも挙動が異なることが確認された。
また、けい皮酸に着目してみると、構造中にカルボン酸を含むけい皮酸ではバイオフィルム形成抑制活性が濃度依存的に認められていたが、エステルであるけい皮酸メチルやけい皮アルデヒドなどの類縁体では、バイオフィルム形成抑制活性は認められなかった。さらに、フェニルプロピオン酸にも活性が認められなかった。このことから、バイオフィルム形成抑制活性を示すためには、けい皮酸構造中にカルボン酸と二重結合が必要であることが示唆された(図2、3)。
各種置換基による活性への影響を確認したところ、メトキシ基が付与したときにのみ、バイオフィルム形成抑制活性を示した。付与する位置についての検討を行ったところ、3位の位置でのみ活性が認められ、2位、4位に付与した場合には、むしろバイオフィルム形成量は増加する傾向が確認された(図4)。また、ジメトキシけい皮酸を用いて、メトキシ基の位置と活性の強弱との相関を確認したところ、3位にメトキシ基が付与した、3,4-ジメトキシけい皮酸と2,3-ジメトキシけい皮酸添加時には濃度依存的なバイオフィルム形成抑制が確認されたが、2,5-ジメトキシけい皮酸では活性は認められなかった(図5)。
メトキシ基の付与する数とバイオフィルム形成抑制活性との関連を調べるため、けい皮酸、メトキシけい皮酸、ジメトキシけい皮酸、トリメトキシけい皮酸を用いて活性を比較した。その結果、メトキシ基の数に比例してバイオフィルム形成量が低下しており、付与するメトキシ基の数がバイオフィルム形成抑制活性に影響を与えていることが確認された(図6)。
下記処方に従って含そう剤を製造した。
エタノール 2.0重量%
2,3,4−トリメトキシけい皮酸 1.0
香料 1.0
水 残
100.0
下記処方に従って練り歯磨きを製造した。
炭酸カルシウム 50.0重量%
グリセリン 19.0
2,3,4−トリメトキシけい皮酸 1.0
カルボオキシメチルセルロース 2.0
ラルリル硫酸ナトリウム 2.0
香料 1.0
サッカリン 0.1
クロルヘキシジン 0.01
水 残
100.0
下記処方に従って口臭用スプレーを製造した。
エタノール 10.0重量%
グリセリン 5.0
2,3,4−トリメトキシけい皮酸 1.0
香料 0.05
着色料 0.001
水 残
100.0
下記処方に従ってトローチを製造した。
2,3,4−トリメトキシけい皮酸 92.3重量%
アラビアガム 6.0
香料 1.0
モノフルオロリン酸ナトリウム 0.7
100.0
下記処方に従ってチューインガムを製造した。
ガムベース 20.0重量%
キシリトール 54.7
マルトース 15.0
ソルビトール 9.3
香料 0.5
2,3,4−トリメトキシけい皮酸 0.5
100.0
下記処方に従ってキャンディを製造した。
砂糖 50.0重量%
還元水あめ 33.0
クエン酸 1.0
香料 0.2
L-メントール 1.0
2,3,4−トリメトキシけい皮酸 0.4
水 残
100.0
下記処方に従って錠菓を製造した。
砂糖 74.7重量%
乳糖 18.9
2,3,4−トリメトキシけい皮酸 2.0
ショ糖脂肪酸エステル 0.15
水 4.25
100.0
下記処方に従ってグミゼリーを製造した。
ゼラチン 60.0重量%
還元水あめ 32.4
2,3,4−トリメトキシけい皮酸 0.5
植物油脂 4.5
リンゴ酸 2.0
香料 0.5
100.0
下記処方に従って飲料を製造した。
オレンジ果汁 30.0重量%
2,3,4−トリメトキシけい皮酸 0.5
クエン酸 0.1
ビタミンC 0.04
香料 0.1
水 残
100.0
Claims (11)
- 少なくとも1種のけい皮酸またはその類縁体を含有する口腔用組成物。
- 前記けい皮酸が、少なくとも1つのメトキシ基を有する請求項1に記載の口腔用組成物。
- 少なくとも1種のけい皮酸またはその類縁体を含有するバイオフィルム形成抑制剤。
- 前記けい皮酸が、少なくとも1つのメトキシ基を有する請求項3に記載のバイオフィルム形成抑制剤。
- 少なくとも1種のけい皮酸またはその類縁体を含有するクオラムセンシング抑制剤。
- 前記けい皮酸が、少なくとも1つのメトキシ基を有する請求項5に記載のクオラムセンシング抑制剤。
- 請求項1または2に記載の口腔用組成物からなる含そう剤。
- 請求項1または2に記載の口腔用組成物からなる練り歯磨き剤。
- 請求項1または2に記載の口腔用組成物からなる吸入剤。
- 請求項1または2に記載の口腔用組成物からなるトローチ剤。
- 請求項1または2に記載の口腔用組成物を含有する食品。
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011196314A JP6016342B2 (ja) | 2011-09-08 | 2011-09-08 | 口腔用組成物 |
KR1020147008975A KR101969610B1 (ko) | 2011-09-08 | 2012-09-06 | 구강용 조성물 |
CN201280043570.8A CN103813777A (zh) | 2011-09-08 | 2012-09-06 | 口腔用组合物 |
PCT/JP2012/005657 WO2013035331A1 (ja) | 2011-09-08 | 2012-09-06 | 口腔用組成物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2011196314A JP6016342B2 (ja) | 2011-09-08 | 2011-09-08 | 口腔用組成物 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016142335A Division JP6389212B2 (ja) | 2016-07-20 | 2016-07-20 | 口腔用組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2013056854A true JP2013056854A (ja) | 2013-03-28 |
JP6016342B2 JP6016342B2 (ja) | 2016-10-26 |
Family
ID=47831800
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2011196314A Active JP6016342B2 (ja) | 2011-09-08 | 2011-09-08 | 口腔用組成物 |
Country Status (4)
Country | Link |
---|---|
JP (1) | JP6016342B2 (ja) |
KR (1) | KR101969610B1 (ja) |
CN (1) | CN103813777A (ja) |
WO (1) | WO2013035331A1 (ja) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102564564B1 (ko) * | 2016-04-21 | 2023-08-04 | 주식회사 엘지생활건강 | 2-메톡시신남알데하이드를 포함하는 구강질환 예방 또는 치료용 조성물 |
CN106306979A (zh) * | 2016-08-18 | 2017-01-11 | 华南农业大学 | 香辛料提取物在食源性致病菌生物膜抑制和清除上的应用 |
EP3753986A4 (en) | 2018-02-13 | 2021-12-15 | Sumitomo Chemical Company Limited | COMPOSITION, AND MOLDED BODY |
JP7080203B2 (ja) | 2019-06-28 | 2022-06-03 | 三菱電機株式会社 | ロボットシステム、組立体の組立方法、組立体の検査方法、電動ハンドの検査方法および電動ハンド性能検査治具 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0360802B2 (ja) * | 1982-08-11 | 1991-09-17 | Hasegawa T Co Ltd | |
JP2001520867A (ja) * | 1997-10-28 | 2001-11-06 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 桂皮酸又はその誘導体に基づく飲料用の防腐剤及び風味剤系 |
JP2003038144A (ja) * | 2001-07-26 | 2003-02-12 | Taiyo Kagaku Co Ltd | 香味成分の劣化防止剤 |
JP2009242309A (ja) * | 2008-03-31 | 2009-10-22 | Ezaki Glico Co Ltd | 皮膚外用剤、口腔用組成物および飲食品 |
JP2009538135A (ja) * | 2006-05-26 | 2009-11-05 | ザ・コカ−コーラ・カンパニー | 保存剤系を含む飲料組成物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0360802A (ja) | 1989-07-31 | 1991-03-15 | Aichi Steel Works Ltd | アングル材の製造方法 |
-
2011
- 2011-09-08 JP JP2011196314A patent/JP6016342B2/ja active Active
-
2012
- 2012-09-06 WO PCT/JP2012/005657 patent/WO2013035331A1/ja active Application Filing
- 2012-09-06 CN CN201280043570.8A patent/CN103813777A/zh active Pending
- 2012-09-06 KR KR1020147008975A patent/KR101969610B1/ko active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0360802B2 (ja) * | 1982-08-11 | 1991-09-17 | Hasegawa T Co Ltd | |
JP2001520867A (ja) * | 1997-10-28 | 2001-11-06 | ユニリーバー・ナームローゼ・ベンノートシヤープ | 桂皮酸又はその誘導体に基づく飲料用の防腐剤及び風味剤系 |
JP2003038144A (ja) * | 2001-07-26 | 2003-02-12 | Taiyo Kagaku Co Ltd | 香味成分の劣化防止剤 |
JP2009538135A (ja) * | 2006-05-26 | 2009-11-05 | ザ・コカ−コーラ・カンパニー | 保存剤系を含む飲料組成物 |
JP2009242309A (ja) * | 2008-03-31 | 2009-10-22 | Ezaki Glico Co Ltd | 皮膚外用剤、口腔用組成物および飲食品 |
Non-Patent Citations (1)
Title |
---|
BODET, C., ET AL., EUR. J. MED. CHEM., vol. 43, JPN6012058657, 2008, pages 1612 - 1620, ISSN: 0003152909 * |
Also Published As
Publication number | Publication date |
---|---|
CN103813777A (zh) | 2014-05-21 |
KR20140069094A (ko) | 2014-06-09 |
JP6016342B2 (ja) | 2016-10-26 |
KR101969610B1 (ko) | 2019-04-16 |
WO2013035331A1 (ja) | 2013-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Pedrazzi et al. | Herbal mouthwash containing extracts of Baccharis dracunculifolia as agent for the control of biofilm: clinical evaluation in humans | |
JP5906011B2 (ja) | 口腔用組成物 | |
JP6016342B2 (ja) | 口腔用組成物 | |
JPH0140005B2 (ja) | ||
EP2146683B1 (fr) | Utilisation d'un extrait aqueux de pepins de raisin en association avec au moins un sel de fluor contre la formation ou l'accumulation du biofilm dentaire et les compositions comprenant cette association | |
Hassan et al. | Comparison of the efficacy of mouth rinses camellia sinensis extract, guava leaves extract and sodium fluoride solution, on Streptococcus mutans and Lactobacillus in children (an in vivo study) | |
KR102008035B1 (ko) | 구강용 조성물 | |
JP6600124B2 (ja) | 菓子 | |
Teke et al. | In vitro antimicrobial activity of some commercial toothpastes | |
JP2010064961A (ja) | 口腔常在菌叢調整剤およびこれを用いた口腔常在菌叢調整方法 | |
JP6389212B2 (ja) | 口腔用組成物 | |
CN108721180B (zh) | 一种含金银花的抑菌口腔组合物、制品及其制备方法 | |
US10918620B2 (en) | Use of statins for periodontal disease and bone regeneration | |
JPH0432047B2 (ja) | ||
KR100492034B1 (ko) | 판두라틴 유도체를 함유하는 충치 및 치주염 예방과치료용 항균제 및 구강 조성물 | |
US10610474B1 (en) | Antibacterial and antifungal dental health formulation | |
JP2015000868A (ja) | 口腔衛生改善活性組成物 | |
CN113694006A (zh) | 一种能够有效抑制牙菌斑的健齿牙膏 | |
KR20130060084A (ko) | 치주질환의 치료 또는 예방용 조성물 | |
JP2016104797A (ja) | 口腔用組成物 | |
WO2010021370A1 (ja) | 口腔用組成物 | |
WO2022054629A1 (ja) | 口腔内フローラ改善・維持剤、プラーク/歯垢の除去及び歯石形成予防剤 | |
JPS63216818A (ja) | う蝕予防剤 | |
JP6921655B2 (ja) | プロテアーゼの阻害剤、バイオフィルムの形成抑制剤、及び口腔用組成物 | |
JP6219458B2 (ja) | 口腔用組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20140904 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20150908 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20151106 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20160421 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20160720 |
|
A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20160727 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20160913 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20160927 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6016342 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |